Federica Martorana

28PUBLICATIONS
79CO-AUTHORS
Molecular targetsPredictive and prognostic markersInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Medical physics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Aug 27, 2026
Clinical Implications of UGT1A1 Polymorphisms in Anticancer Therapy: An Updated Review.

|Jun 24, 2026
Risk stratification and relapse pattern in triple-negative breast cancer with pathological complete response after neoadjuvant treatment: the European GAMBIT real-world study.

|Apr 27, 2026
Preclinical Rationale, Clinical Efficacy, and Safety of the Selective AKT Kinase Inhibitor Capivasertib in Metastatic Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Carcinoma: A Practical Narrative Review.

|Sep 13, 2025
Unlocking the Potential of Immune Checkpoint Inhibitors in HR+/HER2- Breast Cancer: A Systematic Review.

Giuseppe Di Grazia, Arianna Dri, Angela Grieco

|Jul 28, 2025
Correlation between histopathological features and recurrence score according to menopausal status in HR+/HER2- breast cancer patients: a retrospective study.

Federica Martorana, Sabrina Nucera, Gianmarco Motta

|Mar 28, 2025
Real-World Analysis of Adherence to Abemaciclib and Endocrine Therapy in Women with HR+/HER2- Breast Cancer.

Maria Rosaria Valerio, Federica Martorana, Maria Vita Sanò

Pageof 5

Frequent Collaborators

6 joint publications

Vittorio Gebbia

6 joint publications

Paolo Vigneri

5 joint publications

Silvia Rita Vitale

5 joint publications

Giuliana Pavone